Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 Deletion

Overview of attention for article published in Journal of Thoracic Oncology, July 2018

Altmetric Badge

Mentioned by

twitter: 1 X user

Readers on

mendeley: 6 Mendeley

So far, Altmetric has seen 1 X post from an account with 4,081 followers.

Publication co-authored by Dr. Ma: Response to Erlotinib in a Patient with Compound EGFR L747S and Exon 19 Deletion. J Thorac Oncol. 2018 Jul;13(7):e129-e130. https://t.co/vLvaGZB8Vd https://t.co/tXzsy1m5U6

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.